Skip to main content
Fig. 3 | BMC Genomics

Fig. 3

From: Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration

Fig. 3

Haemoglobin concentration, haematocrit (%), reticulocytes (%) and OFF-score in subjects taken rHuEpo in the MDS. Data is displayed by means with corresponding individual changes over time. B: baseline; D: during rHuEpo administration; P: post rHuEpo administration. The number in the parentheses indicates the blood sampling day relative to the day of the first rHuEpo injection (i.e. B3)

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us